Category English

WTO: Antigua To Retaliate Against US By Suspending IP Rights Protection

After years of unsuccessful negotiations between nations, the World Trade Organization Dispute Settlement Body today gave Antigua and Barbuda the right to impose sanctions against the United States for blocking online gambling. The US was found in violation of WTO rules in 2007 and has failed to resolve the issue, so the Caribbean nation was given the right to retaliate in an area that is likely to force a US response - lifting US intellectual property rights.

WHO Board Approves Resolution On Neglected Diseases; Sets Action On Substandard Medicines

The World Health Organization Executive Board today approved a modified resolution on neglected tropical diseases – after removing a reference to a working group on R&D for neglected diseases as “irrelevant”. The Board also discussed and took note of a report on poor quality medical products in the supply chain, and agreed to set another meeting on the issue before the May World Health Assembly, as well as set up a separate group on behaviours that lead to this problem.

Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor

World Health Organization members on Friday held a tense discussion over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development for neglected diseases predominantly afflicting poor populations. The discussion may continue today, with the linkage of an agenda item on neglected tropical diseases and the report of an expert working group offering numerous ideas for addressing the problem.

WHO Plan For Pandemic Flu Proceeds With Questions

The World Health Organization has not completed negotiations with companies on a formula for contribute toward the new WHO framework for pandemic influenza. But companies are paying to access the virus anyway. In its meeting this week, the WHO Executive Board has addressed a range of issues such as pandemic influenza, but so far it has delayed discussion on another contentious topic: substandard/counterfeit medical products.

Governments Put WHO’s Independence At Heart Of Reform Debate

Any employee who has been through a company reform knows that it can be an anxious and stressful period. The experience is no different for the 194 members of the World Health Organization representing their respective countries and the public health interests of their constituents. As the WHO Executive Board digs deep into the fundamental principles of organisational change, preserving the holy member-driven nature of the global public health authority has emerged as the most pressing priority.

Google Report Shows Steady Rise In Government Surveillance

US internet giant Google has released a report showing a steady climb in government surveillance online, which a tech industry group called "disturbing". The report, which covered from July through December of last year, includes more details than in the past, but does not include content takedowns, which now will be the subject of an upcoming separate report.

Philippines Mulls Suspended Cybercrime Law Restricting Communication

Manila, Philippines – The Philippine Supreme Court has begun to hear and weigh the arguments on the constitutionality of a controversial law listing punishable activities on the internet. Its implementation was suspended last year amid mounting criticism that, among other things, the law curtails freedom of speech and harks the country back to the almost a decade of repressive martial rule in the 1970s.

2013: India Battles For Right To Use Compulsory Licences To Make Medicines Affordable

India has started the New Year on a volatile note. With general elections looming in 2014, there is turbulence and not just in the political world. In India’s pharmaceutical industry, there is sparring over the prickly issue of ‘compulsory licenses’, a mechanism by which a government allows a domestic company to manufacture and sell a generic version of a patented drug without the consent of the patent-holder, who receives compensation.